Ebola Vaccine Trials to Start in Switzerland

Ebola vaccine trials are set to start in Switzerland after receiving the green light from the country's authorities, the World Health Organization said.

Swiss regulators announced they would allow trials of an experimental vaccine made by Britain's GlaxoSmithKine, and tests on some 120 individuals were set to get under way at the CHUV hospital in Lausanne this week, the WHO said.

Blackmailers Threaten Czech Republic With Ebola Outbreak
Blackmailers are threatening to spread Ebola in the Czech Republic unless Prague pays them a million euros' worth of the virtual Bitcoin currency, reveals police.

"This marks the latest step towards bringing safe and effective Ebola vaccines for testing and implementation as quickly as possible," the UN's health agency said in a statement.

There is no licensed treatment or vaccine for the deadly Ebola virus, which has killed nearly 5,000 people in the outbreak centred in west Africa.

The experimental GSK vaccine is one of two considered particularly promising by WHO.

CDC Urges 'Active' Monitoring of High-Risk Ebola Workers
Health authorities in US have urged active monitoring of people at risk of Ebola after returning from West Africa but stopped short of recommending a strict quarantine.

Called ChAd3, it is based on a genetically modified chimpanzee adenovirus and trials have already begun in Mali, Britain and the United States, the WHO said.

"The trial will test the safety of the vaccine and its capacity to induce an immune response," it said.

IBM Offers Analytics Platform to Fight Ebola
IBM announced that it would offer its analytics platform and other technology for use in African countries affected by the Ebola epidemic.

It added that results of the trials in Switzerland and elsewhere will "provide the basis for planning subsequent trials involving several thousand participants, and for choosing vaccine dose-level for efficacy trials".

A second experimental vaccine being fast-tracked on the WHO's recommendation, Canadian-discovered rVSV, is set to soon start trials at the University Hospital of Geneva.

Restrictions on Ebola Health Workers Irk UN Chief
UN chief Ban Ki-moon has criticized quarantine restrictions put on health workers returning home.

Trials of that potential vaccine have already begun in the United States and are also set to soon start in Germany, Gabon and Kenya.

"If shown to be safe and effective, either of the vaccines could be scaled up for production during the first quarter of next year, with millions of doses produced for wide distribution in high-risk countries," WHO assistant director general Marie-Paule Kieny said in the statement.

Source-AFP